A detailed history of Clearstead Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 4,387 shares of EW stock, worth $287,260. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,387
Previous 5,753 23.74%
Holding current value
$287,260
Previous $549,000 26.23%
% of portfolio
0.01%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$84.3 - $94.31 $115,153 - $128,827
-1,366 Reduced 23.74%
4,387 $405,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $29,378 - $38,701
-405 Reduced 6.58%
5,753 $549,000
Q4 2023

Feb 12, 2024

SELL
$61.71 - $77.76 $62,203 - $78,382
-1,008 Reduced 14.07%
6,158 $469,000
Q3 2023

Nov 07, 2023

BUY
$69.28 - $93.38 $106,899 - $144,085
1,543 Added 27.44%
7,166 $496,000
Q1 2023

May 09, 2023

BUY
$74.26 - $84.51 $121,637 - $138,427
1,638 Added 41.1%
5,623 $465,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $76,769 - $98,282
1,124 Added 39.29%
3,985 $297,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $4,200 - $5,471
-51 Reduced 1.75%
2,861 $236,000
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $90,133 - $133,657
-1,042 Reduced 26.35%
2,912 $277,000
Q1 2022

May 04, 2022

BUY
$101.96 - $128.34 $107,975 - $135,912
1,059 Added 36.58%
3,954 $465,000
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $21,061 - $25,874
-198 Reduced 6.4%
2,895 $375,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $11,011 - $13,134
-107 Reduced 3.34%
3,093 $350,000
Q2 2021

Aug 12, 2021

BUY
$83.84 - $104.76 $10,647 - $13,304
127 Added 4.13%
3,200 $331,000
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $10,700 - $12,331
136 Added 4.63%
3,073 $257,000
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $30,235 - $39,348
450 Added 18.09%
2,937 $234,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $95,401 - $127,583
1,658 Added 200.0%
2,487 $172,000
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $43,447 - $67,149
829 New
829 $156,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.